" />
HCV antibody RIBA tests - Meaningful Use set:-:Pt: Patient:-:IB - CISMeF
HCV antibody RIBA tests - Meaningful Use set:-:Pt: Patient:-:IBLOINC code
Preferred Label : HCV antibody RIBA tests - Meaningful Use set:-:Pt: Patient:-:IB;
LOINC status : ACTIVE;
LOINC display name : HCV antibody RIBA tests - Meaningful Use set IB;
LOINC long common name : HCV antibody RIBA tests - Meaningful Use set by Immunoblot;
LOINC short name : HCV Ab RIBA MU Set Patient IB;
LOINC description : Panel for qualitative or quantitative tests for Hepatitis C virus antibody using immunoblot
assay (IB) laboratory method. This panel was created for Meaningful Use 3 as part
of a project by the American Medical Association (AMA) to develop three Clinical Quality
Measures for Hepatitis C - 1) One-Time Screening for HCV for Patients at Risk, 2)
HCV Screening for Active Injection Drug Users, and 3) Appropriate Screening Follow-up
for Patients with HCV Infection. This concept may be used by a physician to document
that he/she has reviewed the HCV antibody confirmatory test results performed using
immunoblotting assay (IB) [RIBA] and performed by an outside lab. When the physician
does not know which specific LOINC code to choose when documenting the test and results
from the lab report, this more generic LOINC panel code can be used. The HCV antibody
RIBA panel includes all antibody tests performed using immunoblotting assay (IB) method.
In the eMeasure, this LOINC panel and associated LOINCs codes will be included in
a larger value set for the specific type of screening - HCV RIBA Test.;
Has component